Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galapagos NV (GLPG)

258.99   1.83 (0.71%) 02-14 16:00
Open: 259.17 Pre. Close: 257.16
High: 260.39 Low: 257.51
Volume: 95,482 Market Cap: 16871M
Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 260.684 - 261.719 261.719 - 262.611
Low: 254.618 - 255.909 255.909 - 257.021
Close: 256.781 - 258.868 258.868 - 260.666

Technical analysis

as of: 2020-02-14 4:29:11 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 304.17     One year: 355.27
Support: Support1: 228.15    Support2: 208.20
Resistance: Resistance1: 260.42    Resistance2: 304.17
Pivot: 242.89
Moving Average: MA(5): 257.02     MA(20): 240.43
MA(100): 197.41     MA(250): 158.90
MACD: MACD(12,26): 11.18     Signal(9): 9.67
Stochastic oscillator: %K(14,3): 93.69     %D(3): 93.29
RSI: RSI(14): 72.27
52-week: High: 260.42  Low: 94.75  Change(%): 154.7
Average Vol(K): 3-Month: 13741  10-Days: 17448

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GLPG has closed below upper band by 19.0%. Bollinger Bands are 104.4% wider than normal. The large width of the bands suggest high volatility as compared to GLPG's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fibrocor and Galapagos sign expanded collaboration in fibrosis
Mechelen, Belgium and Toronto, Canada; 15 January 2020, 7.30 CET – Galapagos NV (Euronext & NASDAQ: GLPG) and Fibrocor Therapeutics Inc….

The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL )(agreed to be bought by Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Bristol-Myers Squibb Co (NYSE: BMY )(reacted to ASH presentation) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GlaxoSmithKline plc (NYSE: GSK ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) The Medicines Company (NASDAQ: MDCO ) Merck & Co.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.67
Shares Float (M) 39.79
% Held by Insiders
% Held by Institutions 13.54
Shares Short (K) 1170
Shares Short P. Month (K)

Stock Financials

EPS -1.690
Book Value (p.s.) 25.490
PEG Ratio 0.87
Profit Margin 32.39
Operating Margin
Return on Assets (ttm) 6.8
Return on Equity (ttm) 15.1
Qtrly Rev. Growth 523.9
Gross Profit (p.s.) 2.842
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 2334.00
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -153.25
P/E Growth Ratio 0.01
P/BV 10.16

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.